Solu Therapeutics
Phase 3Solu Therapeutics is a dynamic group of hard-working professionals dedicated to transforming the treatment of diseases by developing groundbreaking medicines.
Founded
2015
Focus
AntibodiesBiologicsSmall Molecules
About
Solu Therapeutics is a dynamic group of hard-working professionals dedicated to transforming the treatment of diseases by developing groundbreaking medicines.
Funding History
1Total raised: $5M
Seed$5MUndisclosedSep 15, 2022
Company Info
TypePrivate
Founded2015
LocationCambridge, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile